Samorita Hospital Limited (DSE:SAMORITA)
Bangladesh · Delayed Price · Currency is BDT 69.90
-0.60 (-0.85%)
At close: Dec 4, 2025
Samorita Hospital Income Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
| 432.25 | 401.37 | 378.39 | 334.27 | 338.09 | 393.62 | Upgrade | |
Revenue Growth (YoY) | 21.70% | 6.07% | 13.20% | -1.13% | -14.11% | 22.53% | Upgrade |
Cost of Revenue | 185.6 | 177.07 | 162.67 | 145.76 | 148.05 | 172.75 | Upgrade |
Gross Profit | 246.65 | 224.29 | 215.72 | 188.5 | 190.04 | 220.87 | Upgrade |
Selling, General & Admin | 187.61 | 181.38 | 170.38 | 157.9 | 141.97 | 147.25 | Upgrade |
Other Operating Expenses | 0.8 | 0.8 | 0.82 | 1.87 | 0.64 | 0.12 | Upgrade |
Operating Expenses | 213.09 | 207.39 | 198.15 | 184.72 | 165.63 | 171.7 | Upgrade |
Operating Income | 33.56 | 16.9 | 17.57 | 3.78 | 24.41 | 49.17 | Upgrade |
Interest Expense | -2.43 | -2.76 | -5.44 | -6.05 | -6.93 | - | Upgrade |
Interest & Investment Income | 1.33 | 1.36 | 2.08 | 2.44 | 3.67 | 4.04 | Upgrade |
Earnings From Equity Investments | 0.12 | 0.1 | 0.04 | 0.04 | 0.04 | -0.07 | Upgrade |
Other Non Operating Income (Expenses) | 2.88 | 2.68 | 2.48 | 2.86 | 2.84 | 1.46 | Upgrade |
EBT Excluding Unusual Items | 35.46 | 18.27 | 16.73 | 3.07 | 24.03 | 54.61 | Upgrade |
Gain (Loss) on Sale of Assets | -0.23 | -0.23 | 0.18 | 0.03 | 0.31 | -0.07 | Upgrade |
Pretax Income | 35.24 | 18.05 | 16.92 | 3.1 | 24.34 | 54.53 | Upgrade |
Income Tax Expense | 12.14 | 4.52 | 4.72 | 2.38 | 8.04 | 12.44 | Upgrade |
Net Income | 23.1 | 13.53 | 12.2 | 0.72 | 16.29 | 42.09 | Upgrade |
Net Income to Common | 23.1 | 13.53 | 12.2 | 0.72 | 16.29 | 42.09 | Upgrade |
Net Income Growth | - | 10.91% | 1593.40% | -95.58% | -61.29% | 1193.89% | Upgrade |
Shares Outstanding (Basic) | 22 | 22 | 22 | 22 | 22 | 22 | Upgrade |
Shares Outstanding (Diluted) | 22 | 22 | 22 | 22 | 22 | 22 | Upgrade |
EPS (Basic) | 1.06 | 0.62 | 0.56 | 0.03 | 0.75 | 1.93 | Upgrade |
EPS (Diluted) | 1.06 | 0.62 | 0.56 | 0.03 | 0.75 | 1.93 | Upgrade |
EPS Growth | - | 10.91% | 1593.42% | -95.58% | -61.29% | 1193.89% | Upgrade |
Free Cash Flow | 36.77 | 16.41 | 26.65 | -0.04 | -11.26 | -21.62 | Upgrade |
Free Cash Flow Per Share | 1.69 | 0.75 | 1.22 | -0.00 | -0.52 | -0.99 | Upgrade |
Dividend Per Share | 0.500 | 0.500 | 0.500 | - | 0.433 | 0.866 | Upgrade |
Dividend Growth | - | - | - | - | -50.00% | - | Upgrade |
Gross Margin | 57.06% | 55.88% | 57.01% | 56.39% | 56.21% | 56.11% | Upgrade |
Operating Margin | 7.76% | 4.21% | 4.64% | 1.13% | 7.22% | 12.49% | Upgrade |
Profit Margin | 5.34% | 3.37% | 3.22% | 0.22% | 4.82% | 10.69% | Upgrade |
Free Cash Flow Margin | 8.51% | 4.09% | 7.04% | -0.01% | -3.33% | -5.49% | Upgrade |
EBITDA | 57.44 | 40.9 | 41.22 | 26.82 | 44.27 | 69.81 | Upgrade |
EBITDA Margin | 13.29% | 10.19% | 10.89% | 8.02% | 13.09% | 17.74% | Upgrade |
D&A For EBITDA | 23.88 | 24 | 23.65 | 23.04 | 19.86 | 20.64 | Upgrade |
EBIT | 33.56 | 16.9 | 17.57 | 3.78 | 24.41 | 49.17 | Upgrade |
EBIT Margin | 7.76% | 4.21% | 4.64% | 1.13% | 7.22% | 12.49% | Upgrade |
Effective Tax Rate | 34.45% | 25.02% | 27.88% | 76.76% | 33.06% | 22.82% | Upgrade |
Advertising Expenses | - | 0.77 | 1.03 | 1.02 | 0.93 | 1.01 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.